NASDAQ:HQYHealthequity Stock Price, Forecast & News

Healthequity's stock was trading at $50.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HQY shares have increased by 30.8% and is now trading at $65.81. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 3 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Healthequity.

Healthequity is scheduled to release its next quarterly earnings announcement on Tuesday, September 1st 2020. View our earnings forecast for Healthequity.

Healthequity Inc (NASDAQ:HQY) announced its earnings results on Tuesday, June, 2nd. The company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by $0.01. The firm had revenue of $190 million for the quarter, compared to analysts' expectations of $193.32 million. Healthequity had a positive return on equity of 9.48% and a negative net margin of 0.05%. Healthequity's revenue for the quarter was up 118.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.31 earnings per share. View Healthequity's earnings history.

Healthequity issued an update on its second quarter earnings guidance on Tuesday, June, 2nd. The company provided earnings per share guidance of $0.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.45. The company issued revenue guidance of $168-$173 million, compared to the consensus revenue estimate of $191.51 million.

14 brokerages have issued 12 month price objectives for Healthequity's shares. Their forecasts range from $47.00 to $87.00. On average, they anticipate Healthequity's stock price to reach $65.69 in the next twelve months. This suggests that the stock has a possible downside of 0.2%. View analysts' price targets for Healthequity.

Press coverage about HQY stock has trended positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Healthequity earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutHealthequity.

Healthequity saw a increase in short interest in May. As of May 15th, there was short interest totaling 3,870,000 shares, an increase of 9.3% from the April 30th total of 3,540,000 shares. Based on an average daily trading volume, of 1,090,000 shares, the short-interest ratio is presently 3.6 days. Currently, 5.6% of the company's stock are sold short. View Healthequity's Current Options Chain.

Some companies that are related to Healthequity include Akamai Technologies (AKAM), Trip.com Group (TCOM), Ctrip.Com International (CTRP), Broadridge Financial Solutions (BR), Zillow Group (Z), Zillow Group (ZG), Fair Isaac (FICO), LYFT (LYFT), The Western Union (WU), Etsy (ETSY), WEX (WEX), Nielsen (NLSN), GrubHub (GRUB), CDK Global (CDK) and Farfetch (FTCH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Shopify (SHOP), Okta (OKTA), Trade Desk (TTD), Paypal (PYPL), Alibaba Group (BABA), Netflix (NFLX), Square (SQ), Twilio (TWLO) and Circle Oil (COP).

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

Healthequity's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.70%), Wasatch Advisors Inc. (3.81%), State Street Corp (3.15%), Alliancebernstein L.P. (2.73%), Fred Alger Management LLC (2.46%) and Janus Henderson Group PLC (2.15%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler and Larry L Trittschuh. View institutional ownership trends for Healthequity.

HQY stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Janus Henderson Group PLC, Invesco Ltd., BlackRock Inc., Two Sigma Advisers LP, Carillon Tower Advisers Inc., and Eagle Asset Management Inc.. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Frank Corvino, Jon Kessler, and Larry L Trittschuh. View insider buying and selling activity for Healthequity.

HQY stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., William Blair Investment Management LLC, ArrowMark Colorado Holdings LLC, Wasatch Advisors Inc., Loomis Sayles & Co. L P, GW&K Investment Management LLC, JPMorgan Chase & Co., and Echo Street Capital Management LLC. View insider buying and selling activity for Healthequity.

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HQY stock can currently be purchased for approximately $65.81.

Healthequity has a market capitalization of $4.70 billion and generates $531.99 million in revenue each year. The company earns $39.66 million in net income (profit) each year or $1.38 on an earnings per share basis. Healthequity employs 2,931 workers across the globe.

The official website for Healthequity is www.healthequity.com.

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]